Measles immunity in HIV-infected children. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Measles immunity in HIV-infected children.

Pediatr AIDS HIV Infect. 1994 Oct;5(5):300-4. Unique Identifier : AIDSLINE AIDS/95330394
Walter EB; Katz SL; Bellini WJ; Department of Pediatrics, Duke University Medical Center, Durham,; North Carolina, USA.

Abstract: In a retrospective study, sera from 84 children of human immunodeficiency virus (HIV)-seropositive mothers (35 HIV-infected and 49 uninfected children) with a known date of receipt of measles, mumps, and rubella vaccine were tested for antibody to measles vaccine by an indirect enzyme immunoassay (EIA) method and/or microneutralization (NEUT). At the time of last measurement, 21/35 (60.0%) HIV-infected children remained seropositive by either EIA or NEUT. Forty seven of forty-nine (95.9%) uninfected children had evidence of measles antibody. Six HIV-infected children had a documented loss of antibody over time. The majority of HIV-infected children had antibody to measles vaccine virus, which in some cases decreased over time.
Keywords: Antibodies, Viral/*ANALYSIS Human HIV Infections/*IMMUNOLOGY Immunization Immunoenzyme Techniques Infant Measles Vaccine/*IMMUNOLOGY Measles Virus/IMMUNOLOGY Mumps Vaccine/IMMUNOLOGY Neutralization Tests Retrospective Studies Rubella Vaccine/IMMUNOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Vaccines, Combined/IMMUNOLOGY JOURNAL ARTICLEKWDantibodies,viral/KWDanalysishumanhivinfections/KWDimmunologyimmunizationimmunoenzymetechniquesinfantmeaslesvaccine/KWDimmunologymeaslesvirus/immunologymumpsvaccine/immunologyneutralizationtestsretrospectivestudiesrubellavaccine/immunologysupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDvaccines,combined/immunologyjournalarticle
951030
M95A0916

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .